Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
253.35B | 227.93B | 208.86B | 165.62B | 154.90B | 110.38B | Gross Profit |
91.72B | 81.38B | 72.71B | 70.19B | 65.45B | 50.65B | EBIT |
23.05B | 17.65B | 5.51B | 19.20B | 19.92B | 16.14B | EBITDA |
39.82B | 35.54B | 24.92B | 29.49B | 30.35B | 24.46B | Net Income Common Stockholders |
19.28B | 16.17B | 2.20B | 15.91B | 13.96B | 14.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
30.70B | 29.65B | 24.26B | 32.83B | 22.91B | 18.71B | Total Assets |
414.69B | 430.65B | 371.35B | 329.94B | 245.67B | 228.14B | Total Debt |
196.17B | 202.36B | 173.06B | 144.13B | 84.77B | 82.39B | Net Debt |
165.47B | 172.71B | 148.81B | 111.30B | 61.85B | 63.68B | Total Liabilities |
265.87B | 274.76B | 234.45B | 197.77B | 129.07B | 123.49B | Stockholders Equity |
148.82B | 155.89B | 136.89B | 132.17B | 116.60B | 104.65B |
Cash Flow | Free Cash Flow | ||||
-16.21B | -31.11B | -27.93B | 8.55B | 2.13B | 14.49B | Operating Cash Flow |
5.70B | 8.21B | 2.54B | 22.13B | 12.01B | 19.16B | Investing Cash Flow |
-23.87B | -40.39B | -30.28B | -59.73B | -9.10B | -39.54B | Financing Cash Flow |
15.58B | 35.41B | 17.48B | 46.54B | 184.00M | 11.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$1.06B | 10.01 | 11.38% | 1.83% | ― | ― | ||
54 Neutral | $5.31B | 3.28 | -45.10% | 2.80% | 16.76% | 0.02% | |
$943.41M | 11.14 | 9.44% | 4.73% | ― | ― | ||
$1.22B | 15.08 | 5.47% | 2.44% | ― | ― | ||
$1.23B | 28.25 | 4.56% | 2.13% | ― | ― | ||
73 Outperform | ¥78.43B | 9.42 | 3.49% | 8.83% | 70.61% | ||
69 Neutral | ¥174.66B | 9.49 | 3.02% | -3.69% | 76.69% |